Telmisartan/hidroklorotiazid Billev Pharma 40 mg/12,5 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

telmisartan/hidroklorotiazid billev pharma 40 mg/12,5 mg tablete

billev pharma aps - hidroklorotiazid, telmisartan - tableta - hidroklorotiazid 12,5 mg / 1 tableta; telmisartan 40 mg / 1 tableta - telmisartan in diuretiki

Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Evropska unija - slovenščina - EMA (European Medicines Agency)

clopidogrel taw pharma (previously clopidogrel mylan)

taw pharma (ireland) limited - klopidogrel hidroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotična sredstva - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Levetiracetam PharmaSwiss 750 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

levetiracetam pharmaswiss 750 mg filmsko obložene tablete

pharmaswiss Česká republika s.r.o. - levetiracetam - filmsko obložena tableta - levetiracetam 750 mg / 1 tableta - levetiracetam

Levetiracetam PharmaSwiss 250 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

levetiracetam pharmaswiss 250 mg filmsko obložene tablete

pharmaswiss Česká republika s.r.o. - levetiracetam - filmsko obložena tableta - levetiracetam 250 mg / 1 tableta - levetiracetam

Levetiracetam PharmaSwiss 1000 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

levetiracetam pharmaswiss 1000 mg filmsko obložene tablete

pharmaswiss Česká republika s.r.o. - levetiracetam - filmsko obložena tableta - levetiracetam 1000 mg / 1 tableta - levetiracetam

Levetiracetam PharmaSwiss 500 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

levetiracetam pharmaswiss 500 mg filmsko obložene tablete

pharmaswiss Česká republika s.r.o. - levetiracetam - filmsko obložena tableta - levetiracetam 500 mg / 1 tableta - levetiracetam

Clopidogrel Acino Pharma Evropska unija - slovenščina - EMA (European Medicines Agency)

clopidogrel acino pharma

acino pharma gmbh - klopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antitrombotična sredstva - clopidogrel je navedeno pri odraslih za preprečevanje atherothrombotic dogodkov v:bolnike, ki trpijo za miokardni infarkt (od nekaj dni do manj kot 35 dni), ischaemic kap (od 7 dni do manj kot 6 mesecev) ali sedež periferne arterijske bolezni. za nadaljnje informacije, prosimo, preberite razdelek 5.

Pregabalin Mylan Pharma Evropska unija - slovenščina - EMA (European Medicines Agency)

pregabalin mylan pharma

mylan s.a.s. - pregabalin - anxiety disorders; neuralgia; epilepsy - antiepileptics, - epilepsypregabalin mylan pharma je označen kot adjunctive terapija pri odraslih z delni epileptični napadi z ali brez sekundarne posplošitev. splošne anksioznosti disorderpregabalin mylan pharma je primerna za zdravljenje splošne anksiozne motnje (gad) pri odraslih.

Fluvastatin Pharmathen 80 mg tablete s podaljšanim sproščanjem Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fluvastatin pharmathen 80 mg tablete s podaljšanim sproščanjem

pharmathen s.a. - fluvastatin - tableta s podaljšanim sproščanjem - fluvastatin 80 mg / 1 tableta - fluvastatin

Skytrofa (previously Lonapegsomatropin Ascendis Pharma) Evropska unija - slovenščina - EMA (European Medicines Agency)

skytrofa (previously lonapegsomatropin ascendis pharma)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hipofize in hipotalamični hormoni in analogi - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.